Clearasil sales
This article was originally published in The Rose Sheet
Executive Summary
Total Care launch in the UK, contributes to brand sales growth of 6.5% to $73.6 mil. in the first half (ended Sept. 30), Boots reports. Flat performance in the U.S. was due to inventory reductions in the trade offsetting rising consumer sales, according to the retailer. Boots Healthcare International sales increased 11.7% in the half to $381.1 mil., while operating profit was up 1.1% to $59.4 mil. Brand investment in the period was up 3% to $121.4 mil., largely due to continued investment behind Clearasil...
|
Total Care launch in the UK, contributes to brand sales growth of 6.5% to $73.6 mil. in the first half (ended Sept. 30), Boots reports. Flat performance in the U.S. was due to inventory reductions in the trade offsetting rising consumer sales, according to the retailer. Boots Healthcare International sales increased 11.7% in the half to $381.1 mil., while operating profit was up 1.1% to $59.4 mil. Brand investment in the period was up 3% to $121.4 mil., largely due to continued investment behind Clearasil.... |